1.7k total citations 50 papers, 1.4k citations indexed
About
Young Rc is a scholar working on Reproductive Medicine, Oncology and Molecular Biology.
According to data from OpenAlex, Young Rc has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Reproductive Medicine, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Young Rc's work include Ovarian cancer diagnosis and treatment (11 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer therapeutics and mechanisms (3 papers). Young Rc is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer therapeutics and mechanisms (3 papers). Young Rc collaborates with scholars based in United States and United Kingdom. Young Rc's co-authors include Levine As, Graw Rg, Schimpff Sc, Von Hoff, Richard L. Schilsky, Franco M. Muggia, Marcel Rozencweig, DeVita Vt, Smith Gp and James Gibbs and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
In The Last Decade
Young Rc
47 papers
receiving
1.2k citations
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
This map shows the geographic impact of Young Rc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Rc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Rc more than expected).
This network shows the impact of papers produced by Young Rc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Rc. The network helps show where Young Rc may publish in the future.
Co-authorship network of co-authors of Young Rc
This figure shows the co-authorship network connecting the top 25 collaborators of Young Rc.
A scholar is included among the top collaborators of Young Rc based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Young Rc. Young Rc is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Rc, Young & S. Pecorelli. (1998). Management of early ovarian cancer.. PubMed. 25(3). 335–9.21 indexed citations
2.
Rc, Young, et al.. (1995). Blood gas/electrolyte analysis during patient evacuation and in the prehospital environment.. PubMed. 14(7). 18–18.
3.
Ihde, DC, et al.. (1988). Management of high risk patients with advanced testis cancer: National Cancer Institute approach.. PubMed. 15(4). 335–8.2 indexed citations
4.
Walton, Leslie, et al.. (1987). Results of second-look laparotomy in patients with early-stage ovarian carcinoma.. PubMed. 70(5). 770–3.19 indexed citations
5.
Rc, Young, et al.. (1986). Modulation of drug resistance in human ovarian cancer: experimental results and clinical applications.. PubMed. 223. 173–85.2 indexed citations
Rc, Young, et al.. (1985). Deep venous thrombosis during therapy for Hodgkin's disease.. PubMed. 69(9). 1011–3.38 indexed citations
8.
Rc, Young. (1984). Ovarian cancer treatment: progress or paralysis?. PubMed. 11(3). 327–9.12 indexed citations
9.
Ostchega, Yechiam, et al.. (1983). MVP (mitomycin, vinblastine, and progesterone): a second-line regimen in ovarian cancer with a high incidence of pulmonary toxicity.. PubMed. 67(7-8). 721–2.16 indexed citations
10.
Rc, Young, et al.. (1980). Plasma desipramine levels after single dosage and at steady state in outpatients.. PubMed. 4(3). 185–8.2 indexed citations
11.
Hoff, Von, et al.. (1980). Toxic effects of cis-dichlorodiammineplatinum(II) in man.. PubMed. 63(9-10). 1527–31.285 indexed citations
12.
Ce, Myers, et al.. (1979). Chemotherapy for murine ovarian cancer: a rationale for ip therapy with adriamycin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(2). 269–73.28 indexed citations
13.
Hoff, Von, et al.. (1978). Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule.. PubMed. 62(10). 1421–6.34 indexed citations
14.
Ba, Chabner, et al.. (1977). Sequential staging in non-Hodgkin's lymphoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(6). 993–7.34 indexed citations
15.
Rc, Young, et al.. (1976). Lung function abnormalities occurring in sickle cell hemoglobinopathies: a preliminary report.. PubMed. 68(3). 201–5, 181.10 indexed citations
16.
Rc, Young. (1975). Chemotherapy of ovarian cancer: past and present.. PubMed. 2(3). 267–76.70 indexed citations
17.
Rc, Young, et al.. (1975). Use of peritoneoscopy for initial staging and posttherapy evaluation of patients with ovarian carcinoma.. PubMed. 42. 81–6.8 indexed citations
18.
Ba, Chabner, Robert W. Sponzo, S M Hubbard, et al.. (1974). High-dose intermittent intravenous infusion of procarbazine (NSC-77213).. PubMed. 57(3). 361–3.7 indexed citations
19.
Rc, Young, et al.. (1974). A new experimental model of hypokinesia.. PubMed. 5. 427–32.11 indexed citations
20.
Rc, Young. (1973). New concepts of delivery of health care to the patient with lung disease.. PubMed. 65(6). 505–11.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.